{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:39:46Z","timestamp":1792895986162,"version":"4.5.0"},"reference-count":210,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semperi.2025.152074","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:02:33Z","timestamp":1743735753000},"page":"152074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pain medication use during pregnancy"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6279-8271","authenticated-orcid":false,"given":"Rebecca A.","family":"Nunge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-9294","authenticated-orcid":false,"given":"Anthony M.","family":"Kendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7485-1962","authenticated-orcid":false,"given":"Sura","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0001","first-page":"205","article-title":"Pregnancy-related low back pain","volume":"15","author":"Katonis","year":"2011","journal-title":"Hippokratia"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00296-014-3135-7","article-title":"Musculoskeletal problems in pregnancy","volume":"35","author":"Thabah","year":"2015","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0003","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/OGX.0b013e318160161c","article-title":"Orthopedic issues in pregnancy","volume":"63","author":"Smith","year":"2008","journal-title":"Obstet Gynecol Surv"},{"issue":"12","key":"10.1016\/j.semperi.2025.152074_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1759720X18812449","article-title":"Musculoskeletal pain and symptoms in pregnancy: a descriptive study","volume":"10","author":"Kesikburun","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00002508-200503000-00006","article-title":"Prevalence of clinical hypertension in patients with chronic pain compared to nonpain general medical patients","volume":"21","author":"Bruehl","year":"2005","journal-title":"Clin J Pain"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7812\/TPP\/05-067","article-title":"Treating chronic pain: new knowledge, more choices","volume":"9","author":"Whitten","year":"2005","journal-title":"Perm J"},{"key":"10.1016\/j.semperi.2025.152074_bib0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/IJWH.S151845","article-title":"Chronic pain during pregnancy: a review of the literature","volume":"10","author":"Ray-Griffith","year":"2018","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.semperi.2025.152074_bib0008","article-title":"Teratogen Information System (TERIS)","year":"2021","journal-title":"Department of Environmental and Occupational Health Sciences University of Washington"},{"key":"10.1016\/j.semperi.2025.152074_bib0009","unstructured":"Reprotox. Reproductive Toxicology Center 2025 [cited 2025 Feb. 1]; Available from: https:\/\/reprotox.org\/about."},{"key":"10.1016\/j.semperi.2025.152074_bib0010","article-title":"Content and format of labeling for Human prescription drug and biological products; requirements for pregnancy and lactation labeling","year":"2014","journal-title":"Food Drug Admin"},{"key":"10.1016\/j.semperi.2025.152074_bib0011","article-title":"Guideline on risk assessment of medicineal products on Human reproduction and lactation: from data to labelling","year":"2008","journal-title":"Eur Med Agency"},{"key":"10.1016\/j.semperi.2025.152074_bib0012","article-title":"MotherToBaby","year":"2025","journal-title":"Organ Teratol Inf Spec"},{"key":"10.1016\/j.semperi.2025.152074_bib0013","unstructured":"Teratology Information Services European Network of teratology Information Services 2025 [cited 2025 Feb. 1]; available from: https:\/\/www.entis-org.eu."},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.09.001","article-title":"Society for Maternal-Fetal Medicine Consult Series #64: systemic lupus erythematosus in pregnancy","volume":"228","author":"Silver","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","article-title":"Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy","volume":"26","author":"Bermas","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"15","key":"10.1016\/j.semperi.2025.152074_bib0016","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"Cmaj"},{"key":"10.1016\/j.semperi.2025.152074_bib0017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.reprotox.2018.05.003","article-title":"No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester - evaluation of the national Embryotox cohort","volume":"79","author":"Dathe","year":"2018","journal-title":"Reprod Toxicol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0018","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/bcp.12653","article-title":"NSAIDs and spontaneous abortions - true effect or an indication bias?","volume":"80","author":"Daniel","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.semperi.2025.152074_bib0019","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.annepidem.2017.09.003","article-title":"Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011","volume":"27","author":"Interrante","year":"2017","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1991.tb00577.x","article-title":"Effect of ibuprofen on alcohol-induced teratogenesis in mice","volume":"15","author":"Randall","year":"1991","journal-title":"Alcohol Clin Exp Res"},{"issue":"8","key":"10.1016\/j.semperi.2025.152074_bib0021","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jpedsurg.2008.10.109","article-title":"Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study","volume":"44","author":"Mac Bird","year":"2009","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13023-023-02992-z","article-title":"Medication use during pregnancy and the risk of gastroschisis: a systematic review and meta-analysis of observational studies","volume":"19","author":"Baldacci","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.semperi.2025.152074_bib0023","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/ajmg.a.34161","article-title":"Limb-body wall defect. Is there a defensible hypothesis and can it explain all the associated anomalies?","volume":"155a","author":"Hunter","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0024","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"Nonsteroidal antiinflammatory drug use among women and the risk of birth defects","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","article-title":"Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study","volume":"77","author":"Ofori","year":"2006","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/bdra.20005","article-title":"Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects","volume":"70","author":"Cleves","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.siny.2004.10.003","article-title":"The pharmacologic closure of the patent ductus arteriosus","volume":"10","author":"Van Overmeire","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0028","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/peds.107.3.519","article-title":"Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn","volume":"107","author":"Alano","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0029","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.2012-0496","article-title":"Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn","volume":"131","author":"Van Marter","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1471-0528.1990.tb01807.x","article-title":"Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour","volume":"97","author":"Hendricks","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0031","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0002-9378(90)90408-Y","article-title":"Oligohydramnios in each sac of a triplet gestation caused by Motrin\u2013fulfilling Kock's postulates","volume":"162","author":"Wiggins","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0032","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF00869093","article-title":"Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents","volume":"8","author":"Kaplan","year":"1994","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0033","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyx235","article-title":"Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child","volume":"47","author":"Petersen","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0034","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/ppe.12596","article-title":"Associations of prenatal or infant exposure to acetaminophen or ibuprofen with mid-childhood executive function and behaviour","volume":"34","author":"Rifas-Shiman","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/all.12897","article-title":"Biomonitoring of prenatal analgesic intake and correlation with infantile anti-aeroallergens IgE","volume":"71","author":"Hoeke","year":"2016","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0036","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0037-1606384","article-title":"The effects of Aspirin in gestation and reproduction (EAGeR) trial: a story of discovery","volume":"35","author":"Connell","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.semperi.2025.152074_bib0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jri.2017.08.001","article-title":"Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: a multicenter study","volume":"122","author":"Deguchi","year":"2017","journal-title":"J Reprod Immunol"},{"issue":"19","key":"10.1016\/j.semperi.2025.152074_bib0038","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1080\/14767058.2017.1350160","article-title":"The effect of low-dose aspirin on fetal weight of idiopathic asymmetrically intrauterine growth restricted fetuses with abnormal umbilical artery doppler indices: a randomized clinical trial","volume":"31","author":"Ali","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0039","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajog.2018.06.011","article-title":"Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women","volume":"219","author":"Andrikopoulou","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.semperi.2025.152074_bib0040","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1515\/jpm-2017-0184","article-title":"Low dose aspirin for preventing fetal growth restriction: a randomised trial","volume":"46","author":"Stanescu","year":"2018","journal-title":"J Perinat Med"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200533","article-title":"Effect of preconception low dose aspirin on pregnancy and live birth according to socioeconomic status: a secondary analysis of a randomized clinical trial","volume":"14","author":"Agrawala","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.semperi.2025.152074_bib0042","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12666","article-title":"Association of treatments for myeloproliferative neoplasms during pregnancy with birth rates and maternal outcomes: a systematic review and meta-analysis","volume":"2","author":"Maze","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0043","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/EDE.0000000000001019","article-title":"Metabolic syndrome and the effectiveness of low-dose aspirin on reproductive outcomes","volume":"30","author":"Nobles","year":"2019","journal-title":"Epidemiology (Fairfax)"},{"issue":"10220","key":"10.1016\/j.semperi.2025.152074_bib0044","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0045","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1080\/14767058.2019.1671348","article-title":"Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation","volume":"33","author":"Karada\u011f","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.semperi.2025.152074_bib0046","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejogrb.2021.05.017","article-title":"Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: a systematic review and meta-analysis","volume":"262","author":"Man","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"10.1016\/j.semperi.2025.152074_bib0047","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0048","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0049","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/OGX.0b013e31815e8731","article-title":"Aspirin and reproductive outcomes","volume":"63","author":"James","year":"2008","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0051","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","article-title":"Maternal medications and environmental exposures as risk factors for gastroschisis","volume":"54","author":"Torfs","year":"1996","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0052","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<241::AID-TERA2>3.0.CO;2-1","article-title":"Prenatal exposure to salicylates and gastroschisis: a case-control study","volume":"56","author":"Mart\u00ednez-Fr\u00edas","year":"1997","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0053","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","article-title":"Maternal medication use and risks of gastroschisis and small intestinal atresia","volume":"155","author":"Werler","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0054","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1586\/17512433.1.5.605","article-title":"Major malformations after first trimester exposure to aspirin and NSAIDs","volume":"1","author":"Nakhai-Pour","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0055","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(78)80453-3","article-title":"Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors","volume":"92","author":"Levin","year":"1978","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0056","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.semperi.2025.152074_bib0057","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"8907","key":"10.1016\/j.semperi.2025.152074_bib0058","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(94)92452-X","article-title":"Follow-up of children in the Italian Study of Aspirin in pregnancy","volume":"343","author":"Parazzini","year":"1994","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0059","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group","volume":"102","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0060","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1542\/peds.2009-0994","article-title":"Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm","volume":"125","author":"Marret","year":"2010","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.semperi.2025.152074_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108210","article-title":"Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years","volume":"9","author":"Thompson","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.semperi.2025.152074_bib0062","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2010.10.021","article-title":"Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence","volume":"126","author":"Gunawardana","year":"2011","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0063","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpn.2014.10.002","article-title":"Antecedents and correlates of visual field deficits in children born extremely preterm","volume":"19","author":"Holm","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0064","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/1471-0528.15561","article-title":"Association of intrauterine exposure to aspirin and blood pressure at 7 years of age: a secondary analysis","volume":"126","author":"Chen","year":"2019","journal-title":"Bjog"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/EDE.0000000000000519","article-title":"In utero exposure to Aspirin and risk of asthma in childhood","volume":"27","author":"Chu","year":"2016","journal-title":"Epidemiology (Fairfax)"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0066","first-page":"451","article-title":"First-trimester drug use and congenital disorders","volume":"65","author":"Aselton","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semperi.2025.152074_bib0067","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03009742.1998.11720785","article-title":"The teratogenicity of antirheumatic drugs\u2013what is the evidence?","volume":"107","author":"K\u00e4ll\u00e9n","year":"1998","journal-title":"Scand J Rheumatol Suppl"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0068","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/sper.2001.27547","article-title":"Adverse and beneficial effects of tocolytic therapy","volume":"25","author":"Pryde","year":"2001","journal-title":"Semin Perinatol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0069","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ogc.2005.04.006","article-title":"Antiprostaglandin drugs","volume":"32","author":"Vermillion","year":"2005","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0070","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1345\/aph.1G428","article-title":"Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis","volume":"40","author":"Koren","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0071","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM198808113190602","article-title":"Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus","volume":"319","author":"Moise","year":"1988","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0072","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.jp.7211612","article-title":"The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants","volume":"27","author":"Cordero","year":"2007","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0073","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajog.2014.10.1091","article-title":"Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis","volume":"212","author":"Hammers","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0074","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ajog.2015.08.022","article-title":"Indomethacin as a tocolytic harmful to preterm infant","volume":"213","author":"Hallman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.AOG.0000168622.56478.df","article-title":"Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis","volume":"106","author":"Loe","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0076","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajog.2007.04.019","article-title":"Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes","volume":"197","author":"Amin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"22","key":"10.1016\/j.semperi.2025.152074_bib0077","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1056\/NEJM199311253292202","article-title":"Neonatal complications after the administration of indomethacin for preterm labor","volume":"329","author":"Norton","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0078","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9378(94)70392-2","article-title":"Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate","volume":"170","author":"Major","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0079","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004310050040","article-title":"Perinatal indomethacin treatment and neonatal complications in preterm infants","volume":"159","author":"Ojala","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0890-6238(94)00051-W","article-title":"The developmental toxicity of indomethacin and sulindac","volume":"9","author":"Lione","year":"1995","journal-title":"Reprod Toxicol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0081","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<282::AID-TERA7>3.0.CO;2-0","article-title":"Teratogen update: fetal effects of indomethacin administration during pregnancy","volume":"56","author":"Norton","year":"1997","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0082","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2003.255","article-title":"A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor","volume":"188","author":"Sawdy","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0083","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s100249900020","article-title":"Nonsteroidal anti-inflammatory drug fetal nephrotoxicity","volume":"1","author":"Bernstein","year":"1998","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0084","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00002018-200124010-00002","article-title":"NSAID-induced nephrotoxicity from the fetus to the child","volume":"24","author":"Cuzzolin","year":"2001","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0085","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2004.07.035","article-title":"Prevention of intraventricular hemorrhage by indomethacin in male preterm infants","volume":"145","author":"Ment","year":"2004","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0086","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1542\/peds.111.4.e340","article-title":"School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial","volume":"111","author":"Vohr","year":"2003","journal-title":"Pediatrics"},{"issue":"bib139","key":"10.1016\/j.semperi.2025.152074_bib0087","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1542\/peds.105.3.485","article-title":"Outcome of children in the indomethacin intraventricular hemorrhage prevention trial","volume":"105","author":"Ment","year":"2000","journal-title":"Pediatrics"},{"issue":"2\u20133","key":"10.1016\/j.semperi.2025.152074_bib0088","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0028-2243(92)90251-S","article-title":"A comparative study of intramuscular ketorolac and pethidine in labour pain","volume":"46","author":"Walker","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.semperi.2025.152074_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijoa.2023.103941","article-title":"Retraction notice to \"A randomized study of the effects of preoperative ketorolac on general anaesthesia for caesarean section\" [Int. J. Obstet. Anesth. 16(3) (2007) 214-220]","volume":"56","author":"El-Tahan","year":"2023","journal-title":"Int J Obstet Anesth"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF01046711","article-title":"The transfer of ketorolac tromethamine from maternal to foetal blood","volume":"34","author":"Walker","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0091","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0028-2243(88)90065-2","article-title":"Effect of maternal ketorolac administration of platelet function in the newborn","volume":"29","author":"Greer","year":"1988","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0092","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ppe.12595","article-title":"Acetaminophen use in pregnancy: examining prevalence, timing, and indication of use in a prospective birth cohort","volume":"34","author":"Bandoli","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0093","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/humupd\/dmaa042","article-title":"Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety","volume":"27","author":"Zafeiri","year":"2021","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9926(199801)57:1<1::AID-TERA1>3.0.CO;2-6","article-title":"Maternal illness, including fever and medication use as risk factors for neural tube defects","volume":"57","author":"Shaw","year":"1998","journal-title":"Teratology"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/bdra.10130","article-title":"Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies","volume":"67","author":"Abe","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0096","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0b013e3181c52616","article-title":"Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study","volume":"115","author":"Feldkamp","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0097","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/bdr2.1441","article-title":"A machine learning approach to investigate potential risk factors for gastroschisis in California","volume":"111","author":"Weber","year":"2019","journal-title":"Birth Defects Res"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0098","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ajog.2007.08.040","article-title":"Acetaminophen use during pregnancy: effects on risk for congenital abnormalities","volume":"198","author":"Rebordosa","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0099","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/EDE.0b013e31821eca69","article-title":"Analgesics during pregnancy and cryptorchidism: additional analyses","volume":"22","author":"Jensen","year":"2011","journal-title":"Epidemiology (Fairfax)"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/humrep\/der474","article-title":"Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study","volume":"27","author":"Snijder","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0101","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/humrep\/deq323","article-title":"Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat","volume":"26","author":"Kristensen","year":"2011","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0102","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/rheumatology\/keab623","article-title":"Prenatal acetaminophen use in women with autoimmune disorders and adverse pregnancy and birth outcomes","volume":"61","author":"Killion","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14740338.2022.2020246","article-title":"Effect of acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"21","author":"Castro","year":"2022","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41390-019-0379-7","article-title":"Comparison of fetal growth by maternal prenatal acetaminophen use","volume":"86","author":"Smarr","year":"2019","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0105","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/01.smj.0000184792.15407.51","article-title":"Acetaminophen overdose in pregnancy","volume":"98","author":"Wilkes","year":"2005","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0106","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13181-012-0218-2","article-title":"Unintentional chronic acetaminophen poisoning during pregnancy resulting in liver transplantation","volume":"8","author":"Thornton","year":"2012","journal-title":"J Med Toxicol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0107","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.transproceed.2012.10.046","article-title":"Accidental acetaminophen overdose results in liver transplant during second trimester of pregnancy: a case report","volume":"45","author":"Franko","year":"2013","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.semperi.2025.152074_bib0108","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41574-021-00553-7","article-title":"Paracetamol use during pregnancy - a call for precautionary action","volume":"17","author":"Bauer","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0004867418823276","article-title":"Association of maternal prenatal acetaminophen use with the risk of attention deficit\/hyperactivity disorder in offspring: a meta-analysis","volume":"53","author":"Gou","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","article-title":"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders","volume":"168","author":"Liew","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0111","first-page":"140","article-title":"Prenatal exposure to acetaminophen and risk of ADHD","author":"Ystrom","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40572-020-00301-5","article-title":"Intrauterine exposure to acetaminophen and adverse developmental outcomes: epidemiological findings and methodological issues","volume":"8","author":"Liew","year":"2021","journal-title":"Curr Environ Health Rep"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0113","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41574-021-00606-x","article-title":"Paracetamol use in pregnancy - caution over causal inference from available data","volume":"18","author":"Alwan","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41574-021-00605-y","article-title":"Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy","volume":"18","author":"Damkier","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"14","key":"10.1016\/j.semperi.2025.152074_bib0115","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2024.3172","article-title":"Acetaminophen use during pregnancy and children's risk of Autism, ADHD, and intellectual disability","volume":"331","author":"Ahlqvist","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0116","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/AOG.0000000000005802","article-title":"Acetaminophen in pregnancy and Attention-Deficit and Hyperactivity disorder and Autism spectrum disorder","volume":"145","author":"Damkier","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0117","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2014.07.065","article-title":"Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children","volume":"135","author":"Sordillo","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0118","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3109\/14767058.2012.696162","article-title":"Antenatal dexamethasone has no adverse effects on child physical and cognitive development: a long-term cohort follow-up investigation","volume":"25","author":"Liu","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0119","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01090-2018","article-title":"Prescribed analgesics in pregnancy and risk of childhood asthma","volume":"53","author":"Shaheen","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/jech-2017-209960","article-title":"Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study","volume":"72","author":"Piler","year":"2018","journal-title":"J Epidemiol Community Health"},{"issue":"8","key":"10.1016\/j.semperi.2025.152074_bib0121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135775","article-title":"Prenatal paracetamol exposure and wheezing in childhood: causation or confounding?","volume":"10","author":"Migliore","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.semperi.2025.152074_bib0122","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.placenta.2004.12.008","article-title":"The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome","volume":"26","author":"van Runnard Heimel","year":"2005","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0123","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0124","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4","article-title":"Corticosteroids during pregnancy and oral clefts: a case-control study","volume":"58","author":"Rodr\u00edguez-Pinilla","year":"1998","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0126","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U","article-title":"Maternal corticosteroid use and risk of selected congenital anomalies","volume":"86","author":"Carmichael","year":"1999","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0127","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2003.10.007","article-title":"Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study","volume":"18","author":"Gur","year":"2004","journal-title":"Reprod Toxicol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03009742.2011.626442","article-title":"Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers","volume":"41","author":"Viktil","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semperi.2025.152074_bib0130","series-title":"Birth Defects and Drugs in Pregnancy","author":"Heinonen","year":"1977"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/096120339600500205","article-title":"Factors associated with fetal losses in severe systemic lupus erythematosus","volume":"5","author":"Mart\u00ednez-Rueda","year":"1996","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0132","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0091-6749(86)80088-4","article-title":"Outcome of pregnancy in women requiring corticosteroids for severe asthma","volume":"78","author":"Fitzsimons","year":"1986","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0133","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-94-5-667","article-title":"Systemic lupus erythematosus in pregnancy","volume":"94","year":"1981","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0134","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00431-009-1095-9","article-title":"Hypoglycaemic seizure and neonatal acute adrenal insufficiency after maternal exposure to prednisone during pregnancy: a case report","volume":"169","author":"Saulnier","year":"2010","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0136","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-3476(74)80109-5","article-title":"Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy","volume":"85","author":"Cot\u00e9","year":"1974","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0137","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.160.5.610","article-title":"The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation","volume":"160","author":"Janssen","year":"2000","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.semperi.2025.152074_bib0138","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120552","article-title":"Fetal toxicity of immunosuppressive drugs in pregnancy","volume":"7","author":"Ponticelli","year":"2018","journal-title":"J Clin Med"},{"issue":"55","key":"10.1016\/j.semperi.2025.152074_bib0139","first-page":"37","article-title":"Long-term follow-up of children with in utero exposure to immunosuppressives","author":"Rieder","year":"1997","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clp.2011.06.013","article-title":"Controversy: antenatal steroids","volume":"38","author":"Wapner","year":"2011","journal-title":"Clin Perinatol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0141","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ogc.2011.12.006","article-title":"Antenatal corticosteroids in the management of preterm birth: are we back where we started?","volume":"39","author":"Bonanno","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0142","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1136\/archdischild-2013-304705","article-title":"Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study","volume":"99","author":"Wong","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0143","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/02770900500448803","article-title":"A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring","volume":"43","author":"Tam\u00e1si","year":"2006","journal-title":"J Asthma"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0144","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W","article-title":"Population-based case-control study of teratogenic potential of corticosteroids","volume":"56","author":"Czeizel","year":"1997","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0145","first-page":"485","article-title":"Antenatal dexamethasone and decreased birth weight","volume":"97","author":"Bloom","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0146","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1542\/peds.2007-1103","article-title":"Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone","volume":"121","author":"Lee","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.semperi.2025.152074_bib0147","series-title":"Treatment For Acute pain: a Systematic Review","author":"Chou","year":"2020"},{"issue":"9","key":"10.1016\/j.semperi.2025.152074_bib0148","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"issue":"71","key":"10.1016\/j.semperi.2025.152074_bib0149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for prescribing opioids for pain\u2014 United States","volume":"2022","author":"Dowell","year":"2022","journal-title":"MMWR Recomm rep"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0150","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"1\u20132","key":"10.1016\/j.semperi.2025.152074_bib0151","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"issue":"25","key":"10.1016\/j.semperi.2025.152074_bib0152","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa2214470","article-title":"Eat, sleep, console approach or usual care for neonatal opioid withdrawal","volume":"388","author":"Young","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0153","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.semperi.2025.152074_bib0154","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0155","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/add.12078","article-title":"Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women","volume":"108","author":"Cleary","year":"2013","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0156","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ADM.0000000000000463","article-title":"Prenatal opioid exposure, neonatal abstinence syndrome\/neonatal Opioid withdrawal syndrome, and later child development research: shortcomings and solutions","volume":"13","author":"Jones","year":"2019","journal-title":"J Addict Med"},{"issue":"8","key":"10.1016\/j.semperi.2025.152074_bib0157","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of Methadone vs Morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial","volume":"172","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.semperi.2025.152074_bib0158","series-title":"Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors Table For Presciption Drug Coverage","year":"2020"},{"key":"10.1016\/j.semperi.2025.152074_bib0159","series-title":"Codeine, in StatPearls","author":"Peechakara","year":"2025"},{"issue":"12","key":"10.1016\/j.semperi.2025.152074_bib0160","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","article-title":"Effects of codeine on pregnancy outcome: results from a large population-based cohort study","volume":"67","author":"Nezvalov\u00e1-Henriksen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.semperi.2025.152074_bib0161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219061","article-title":"Pregnancy outcome following opioid exposure: a cohort study","volume":"14","author":"Fishman","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0162","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5708","article-title":"Association of gestational opioid exposure and risk of major and Minor congenital malformations","volume":"4","author":"Wen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0163","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0164","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/AOG.0b013e3182a6643c","article-title":"Periconceptional use of opioids and the risk of neural tube defects","volume":"122","author":"Yazdy","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/EDE.0000000000001328","article-title":"Prenatal opioid analgesics and the risk of adverse birth outcomes","volume":"32","author":"Brogly","year":"2021","journal-title":"Epidemiology (Fairfax)"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0166","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/pds.5009","article-title":"In utero exposure to analgesic opioids and language development in 5-year old children","volume":"29","author":"Skovlund","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.semperi.2025.152074_bib0167","series-title":"Hydrocodone, in StatPearls","author":"Cofano","year":"2025"},{"key":"10.1016\/j.semperi.2025.152074_bib0168","article-title":"Consumption of prescription opioids for pain: a comprison of opioid use in the United States and other countries","author":"Duff","year":"2021","journal-title":"Congress Res Serv"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0169","first-page":"139","article-title":"Maternal use of opioids during pregnancy and congenital malformations: a systematic review","author":"Lind","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5055\/jom.2019.0529","article-title":"Birth outcomes with prescribed chronic and acute opioid exposure during pregnancy","volume":"15","author":"Delate","year":"2019","journal-title":"J Opioid Manag"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0171","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/AOG.0000000000004714","article-title":"Exposure to tramadol during early pregnancy and risk of spontaneous abortion or major congenital malformations","volume":"139","author":"S\u00f8rensen","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0172","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1503\/cmaj.211215","article-title":"Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study","volume":"194","author":"Bowie","year":"2022","journal-title":"Cmaj"},{"issue":"8","key":"10.1016\/j.semperi.2025.152074_bib0173","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28588","article-title":"Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns","volume":"5","author":"Esposito","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0174","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-017-0763-8","article-title":"A retrospective cohort study of birth outcomes in neonates exposed to naltrexone in utero: a comparison with methadone-, buprenorphine- and non-opioid-exposed neonates","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajog.2010.10.004","article-title":"Methadone and perinatal outcomes: a retrospective cohort study","volume":"204","author":"Cleary","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0176","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/archdischild-2019-316804","article-title":"Methadone, Pierre Robin sequence and other congenital anomalies: case-control study","volume":"105","author":"Cleary","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1\u20132","key":"10.1016\/j.semperi.2025.152074_bib0177","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series","volume":"96","author":"Kakko","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.semperi.2025.152074_bib0178","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00228-011-1049-9","article-title":"Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study","volume":"67","author":"Lacroix","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0179","first-page":"254","article-title":"The effects of methadone treatment on the reactivity of the nonstress test","volume":"74","author":"Archie","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0180","first-page":"229","article-title":"Methadone maintenance treatment and the nonstress test","volume":"15","author":"Levine","year":"1995","journal-title":"J Perinatol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0181","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1754.1995.tb00857.x","article-title":"Cleft palate, mortality and morbidity in infants of substance abusing mothers","volume":"31","author":"Thomas","year":"1995","journal-title":"J Paediatr Child Health"},{"issue":"24","key":"10.1016\/j.semperi.2025.152074_bib0182","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.semperi.2025.152074_bib0183","first-page":"5","article-title":"Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study","volume":"9","author":"N\u00f8rgaard","year":"2015","journal-title":"Subst Abuse"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0184","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1651-2227.2003.tb00561.x","article-title":"Strabismus in infants of opiate-dependent mothers","volume":"92","author":"Gill","year":"2003","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaapos.2017.05.025","article-title":"Sensorimotor outcomes in children with prenatal exposure to methadone","volume":"21","author":"Yoo","year":"2017","journal-title":"J aapos"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0186","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41433-023-02644-3","article-title":"Impaired vision in children prenatally exposed to methadone: an observational cohort study","volume":"38","author":"Hamilton","year":"2024","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0187","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.earlhumdev.2014.10.006","article-title":"Infants of opioid-dependent mothers: neurodevelopment at six months","volume":"91","author":"McGlone","year":"2015","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.semperi.2025.152074_bib0188","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.earlhumdev.2017.11.010","article-title":"Early inhibitory control and working memory abilities of children prenatally exposed to methadone","volume":"116","author":"Levine","year":"2018","journal-title":"Early Hum Dev"},{"issue":"10","key":"10.1016\/j.semperi.2025.152074_bib0189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240905","article-title":"Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months","volume":"15","author":"Wouldes","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0190","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/09297049.2014.967201","article-title":"Executive function in preschool children prenatally exposed to methadone or buprenorphine","volume":"21","author":"Konijnenberg","year":"2015","journal-title":"Child Neuropsychol"},{"key":"10.1016\/j.semperi.2025.152074_bib0191","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","article-title":"Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes","volume":"185","author":"Kaltenbach","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.semperi.2025.152074_bib0192","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejogrb.2014.08.013","article-title":"Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy","volume":"181","author":"Guttuso","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0193","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.semperi.2025.152074_bib0194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003322","article-title":"Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid Analytic eXtract dataset","volume":"17","author":"Patorno","year":"2020","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ppe.13086","article-title":"Risks of congenital malformations and neonatal intensive care unit admissions with gabapentin use in pregnancy: a cohort study and scoping review with meta-analysis","volume":"38","author":"Desrochers","year":"2024","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.semperi.2025.152074_bib0196","doi-asserted-by":"crossref","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.semperi.2025.152074_bib0197","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpeds.2016.11.004","article-title":"An Atypical withdrawal syndrome in neonates prenatally exposed to gabapentin and opioids","volume":"181","author":"Loudin","year":"2017","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.semperi.2025.152074_bib0198","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pediatrneurol.2015.06.023","article-title":"Neonatal Gabapentin withdrawal Syndrome","volume":"53","author":"Carrasco","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152074_bib0199","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034829","article-title":"Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study","volume":"10","author":"Bloti\u00e8re","year":"2020","journal-title":"BMJ Open"},{"issue":"24","key":"10.1016\/j.semperi.2025.152074_bib0200","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1212\/WNL.0000000000002767","article-title":"Pregnancy outcome following maternal exposure to pregabalin may call for concern","volume":"86","author":"Winterfeld","year":"2016","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.semperi.2025.152074_bib0201","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1212\/WNL.0000000000003959","article-title":"Pregabalin use early in pregnancy and the risk of major congenital malformations","volume":"88","author":"Patorno","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.semperi.2025.152074_bib0202","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40264-023-01307-2","article-title":"Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries","volume":"46","author":"Dudukina","year":"2023","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.semperi.2025.152074_bib0203","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0149-2918(03)80067-X","article-title":"Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials","volume":"25","author":"Borenstein","year":"2003","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.semperi.2025.152074_bib0204","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/pds.5619","article-title":"Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to evaluate pregnancy exposureS (2014-2018","volume":"32","author":"Fisher","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"10.1016\/j.semperi.2025.152074_bib0205","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3109\/14767058.2013.850663","article-title":"Maternal use of cyclobenzaprine (Flexeril) may induce ductal closure and persistent pulmonary hypertension in neonates","volume":"27","author":"Moreira","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.semperi.2025.152074_bib0206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2176\/nmccrj.cr.2017-0191","article-title":"Pregnancy and breastfeeding during intrathecal Baclofen therapy - A case study and review","volume":"5","author":"Hara","year":"2018","journal-title":"NMC Case Rep J"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0207","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.reprotox.2012.05.046","article-title":"Pregnancy outcomes after in utero exposure to baclofen","volume":"34","author":"N Bernard","year":"2012","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152074_bib0208","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1542\/peds.114.2.e267","article-title":"Intrauterine baclofen exposure: a multidisciplinary approach","volume":"114","author":"Moran","year":"2004","journal-title":"Pediatrics"},{"issue":"7304","key":"10.1016\/j.semperi.2025.152074_bib0209","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.323.7304.85","article-title":"Drug points: neonatal convulsions after withdrawal of baclofen","volume":"323","author":"Ratnayaka","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semperi.2025.152074_bib0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12028-010-9422-6","article-title":"Acute intrathecal baclofen withdrawal: a brief review of treatment options","volume":"14","author":"Ross","year":"2011","journal-title":"Neurocrit Care"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:21:59Z","timestamp":1749590519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000525000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":210,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0146000525000515"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152074","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain medication use during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152074"}}